NRXP NRX Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1719406 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 35 since 2021-11-02, latest 2026-02-17
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 28
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-18 | 2024-12-17 | NRXP | Javitt Jonathan C | COB, Chief Scientist, Dir, 10% | P - Purchase | $1.17 | +40.0K | 84.6K | +90% | +$46.8K | |
| 2023-09-11 | 2023-08-30 | NRXP | Hurvitz Chaim | Dir | P - Purchase | $0.29 | +70.0K | 570.0K | +14% | +$20.3K | |
| I | 2023-09-11 | 2023-08-30 | NRXP | Gorovitz Aaron | Dir | P - Purchase | $0.32 | +35.0K | 105.0K | +50% | +$11.2K |
| 2023-08-24 | 2023-08-23 | NRXP | Javitt Jonathan C | Chief Scientist, Dir, 10% | P - Purchase | $0.33 | +100.0K | 446.3K | +29% | +$33.0K | |
| 2023-08-23 | 2023-08-22 | NRXP | Javitt Jonathan C | Chief Scientist, Dir, 10% | P - Purchase | $0.32 | +200.0K | 346.3K | +137% | +$64.0K | |
| MA | 2022-12-19 | 2022-11-25 | NRXP | VAN VOORHEES SETH | CFO | P - Purchase | $1.11 | +16.3K | 16.3K | New | +$18.2K |
| 2022-12-19 | 2022-12-16 | NRXP | VAN VOORHEES SETH | CFO | P - Purchase | $1.10 | +30.0K | 46.3K | +184% | +$33.0K | |
| 2022-12-19 | 2022-12-16 | NRXP | Willard Stephen H | CEO, Dir | P - Purchase | $1.17 | +50.0K | 50.0K | New | +$58.5K | |
| I | 2022-12-09 | 2022-12-07 | NRXP | Javitt Jonathan C | Dir, 10% | S - Sale | $1.00 | -400.0K | 12.90M | -3% | -$400.0K |
| MI | 2022-12-01 | 2022-11-29+ | NRXP | Javitt Daniel C. | 10% | S - Sale | $1.50 | -22.2K | 9.63M | -0.2% | -$33.3K |
| MI | 2022-11-29 | 2022-11-28 | NRXP | Flynn Patrick John | Dir | P - Purchase | $1.25 | +10.0K | 37.7K | +36% | +$12.5K |
| 2022-11-29 | 2022-11-28 | NRXP | Flynn Patrick John | Dir | P - Purchase | $1.25 | +1,750 | 1,750 | New | +$2,188 | |
| MI | 2022-11-28 | 2022-11-25 | NRXP | VAN VOORHEES SETH | CFO | P - Purchase | $1.11 | +16.3K | 8,716 | New | +$18.2K |
| MA | 2022-11-23 | 2022-11-16+ | NRXP | Hurvitz Chaim | Dir | P - Purchase | $1.03 | +500.0K | 459.6K | New | +$514.9K |
| DM | 2022-11-21 | 2022-11-16+ | NRXP | Hurvitz Chaim | Dir | P - Purchase | $1.03 | +500.0K | 459.6K | New | +$514.9K |
| MI | 2022-11-18 | 2022-11-16+ | NRXP | Javitt Daniel C. | 10% | S - Sale | $1.03 | -166.7K | 9.66M | -2% | -$171.1K |
| I | 2022-11-15 | 2022-11-11 | NRXP | Javitt Daniel C. | 10% | S - Sale | $1.01 | -49.2K | 9.82M | -0.5% | -$49.7K |
| I | 2022-08-02 | 2022-07-29 | NRXP | Javitt Daniel C. | 10% | S - Sale | $1.01 | -784.1K | 9.87M | -7% | -$791.9K |
| I | 2022-07-05 | 2022-07-01 | NRXP | Javitt Daniel C. | 10% | G - Gift | $0.00 | -2.00M | 10.66M | -16% | $0 |
| MI | 2022-06-07 | 2022-06-03+ | NRXP | Javitt Daniel C. | 10% | S - Sale | $0.6825 | -445.7K | 12.86M | -3% | -$304.2K |
| 2022-06-02 | 2022-06-01 | NRXP | Javitt Jonathan C | Chief Scientist, Dir, 10% | P - Purchase | $58.00 | +100.0K | 146.3K | +216% | +$5.80M | |
| A | 2022-06-02 | 2022-06-01 | NRXP | Javitt Jonathan C | Chief Scientist, Dir, 10% | P - Purchase | $0.58 | +100.0K | 146.3K | +216% | +$58.0K |
| MI | 2021-11-02 | 2021-07-16 | NRXP | Javitt Daniel C. | 10% | G - Gift | — | -869.2K | 13.10M | -6% | — |
| D | 2021-11-02 | 2021-08-16 | NRXP | Besthof Robert | Chief Comm, Patient Off | M - OptEx | $0.2 | +63.7K | 63.7K | New | +$12.7K |
| D | 2021-11-02 | 2021-09-15 | NRXP | Besthof Robert | Chief Comm, Patient Off | S - Sale+OE | $11.76 | -40.0K | 23.7K | -63% | -$470.4K |
| DM | 2021-11-02 | 2021-08-19+ | NRXP | Daigneault Alessandra | GC, Sec | M - OptEx | $3.07 | +59.0K | 33.7K | New | +$181.1K |
| D | 2021-11-02 | 2021-08-23 | NRXP | Daigneault Alessandra | GC, Sec | S - Sale+OE | $13.11 | -33.7K | 0 | -100% | -$442.0K |
| D | 2021-11-02 | 2021-08-26 | NRXP | McMaster Herbert Raymond | Dir | M - OptEx | $2.22 | +18.3K | 18.3K | New | +$40.6K |
Purchase Sale Sale after option exercise All abbreviations